Vlado Perkovic Selected Research

Canagliflozin

10/2022	Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
1/2022	Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial.
1/2022	Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease.
1/2022	The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial.
1/2022	Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.
1/2022	Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial.
1/2022	Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
12/2021	Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
12/2021	Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
12/2021	Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vlado Perkovic Research Topics

Disease

116	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2006
68	Chronic Renal Insufficiency 10/2022 - 10/2007
48	Albuminuria 01/2022 - 08/2009
37	Heart Failure 10/2022 - 12/2009
35	Kidney Diseases (Kidney Disease) 01/2022 - 06/2012
34	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 08/2009
30	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 12/2009
26	Stroke (Strokes) 01/2022 - 10/2007
24	Renal Insufficiency (Renal Failure) 01/2022 - 01/2003
23	Vascular Diseases (Vascular Disease) 11/2019 - 08/2006
20	Myocardial Infarction 01/2022 - 03/2012
19	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2011
17	Body Weight (Weight, Body) 01/2022 - 08/2013
15	Proteinuria 09/2021 - 03/2008
14	Infections 01/2022 - 08/2013
9	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 06/2010
9	Hemorrhage 06/2017 - 03/2012
7	Hypotension (Low Blood Pressure) 01/2020 - 03/2015
7	Thrombosis (Thrombus) 05/2016 - 07/2010
6	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 06/2012
6	Anemia 01/2022 - 01/2015
6	Hypertension (High Blood Pressure) 01/2021 - 10/2006
6	Hypoglycemia (Reactive Hypoglycemia) 12/2020 - 01/2011
6	Diabetes Mellitus 01/2020 - 12/2012
5	Atrial Fibrillation 10/2022 - 02/2015
5	Hyperkalemia 10/2022 - 12/2015
5	Neoplasms (Cancer) 05/2014 - 05/2010
5	Rhabdomyolysis 05/2014 - 04/2009
4	Weight Gain 06/2020 - 09/2015
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 10/2007
3	Ischemic Stroke 10/2022 - 06/2017
3	Hypoxia (Hypoxemia) 01/2022 - 12/2021
3	Inflammation (Inflammations) 12/2021 - 10/2012
3	Edema (Dropsy) 12/2021 - 05/2014
3	Pancreatitis 12/2020 - 09/2018
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019 - 10/2012
3	Coronary Disease (Coronary Heart Disease) 10/2012 - 10/2008

Drug/Important Bio-Agent (IBA)

55	CanagliflozinIBA 10/2022 - 08/2013
51	CreatinineIBA 01/2022 - 04/2009
31	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2006
30	AlbuminsIBA 01/2022 - 10/2008
20	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2014
20	perindopril drug combination indapamideIBA 11/2019 - 08/2006
20	Gliclazide (Diamicron)IBA 11/2019 - 08/2006
18	SodiumIBA 01/2022 - 08/2013
15	Sodium-Glucose Transport ProteinsIBA 10/2022 - 03/2015
14	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2009
13	AtrasentanIBA 01/2022 - 05/2014
13	Pharmaceutical PreparationsIBA 01/2021 - 10/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2009
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 03/2008
12	LinagliptinIBA 09/2021 - 11/2013
11	SymportersIBA 01/2022 - 08/2013
11	Perindopril FDA LinkGeneric 01/2019 - 01/2006
10	HematinicsIBA 01/2022 - 07/2010
9	Indapamide FDA LinkGeneric 01/2019 - 01/2006
7	DiureticsIBA 10/2022 - 10/2006
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 09/2011
7	EnzymesIBA 01/2015 - 04/2009
7	LipidsIBA 05/2014 - 03/2008
6	PotassiumIBA 10/2022 - 12/2015
6	Uric Acid (Urate)IBA 01/2022 - 01/2011
6	Erythropoietin FDA Link 12/2021 - 08/2013
6	CholesterolIBA 01/2020 - 03/2008
5	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2009
5	Endothelin Receptor AntagonistsIBA 01/2022 - 05/2014
5	Phosphates (Orthophosphate)IBA 11/2020 - 07/2012
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 03/2009
5	Warfarin (Coumadin)FDA LinkGeneric 06/2017 - 11/2013
4	Prolyl-Hydroxylase InhibitorsIBA 01/2022 - 12/2021
4	Insulin (Novolin)FDA Link 01/2022 - 03/2015
4	HDL CholesterolIBA 01/2022 - 11/2011
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 11/2020
4	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2017
4	GSK1278863IBA 01/2022 - 12/2021
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 09/2015
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 10/2014
4	Angiotensin Receptor AntagonistsIBA 01/2020 - 09/2011
4	AnticoagulantsIBA 01/2019 - 11/2013
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 03/2012
3	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 02/2014
3	Darbepoetin alfa (Aranesp)FDA Link 01/2022 - 12/2021
3	SteroidsIBA 01/2021 - 06/2012
3	empagliflozinIBA 12/2020 - 01/2017
3	Parathyroid Hormone (Parathormone)IBA 12/2019 - 01/2003
3	Endothelin A ReceptorIBA 11/2019 - 05/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 06/2012
3	Pentoxifylline (Trental)FDA LinkGeneric 07/2017 - 01/2015
3	HomocysteineIBA 05/2016 - 06/2012
3	LDL CholesterolIBA 01/2016 - 03/2008
3	Creatine Kinase (Creatine Phosphokinase)IBA 05/2014 - 09/2013
3	Proteins (Proteins, Gene)FDA Link 09/2013 - 10/2008

Therapy/Procedure

49	Therapeutics 10/2022 - 08/2006
10	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 06/2010
6	Kidney Transplantation 01/2021 - 05/2010
6	Glycemic Control 12/2020 - 03/2009
6	Surgical Amputation (Amputations) 10/2020 - 05/2016
5	Renal Dialysis (Hemodialysis) 01/2021 - 01/2013
4	Transplantation 01/2021 - 05/2010